Search

Your search keyword '"Biancone L"' showing total 1,516 results

Search Constraints

Start Over You searched for: Author "Biancone L" Remove constraint Author: "Biancone L"
1,516 results on '"Biancone L"'

Search Results

1. Colistin Therapy, Survival and Renal Replacement Therapy in Burn Patients: A 10-Year Single-Center Cohort Study

2. Urinary protein profiles in ketorolac-associated acute kidney injury in patients undergoing orthopedic day surgery

4. T.05.3: NEW OR RECURRENT CANCER IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH IMMUNOMODULATORS OR BIOLOGICS AFTER CANCER

5. OC.13.1: PREVENTABLE FACTORS OF POST-COLONOSCOPY COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE PATIENTS

9. P908 Real-life effectiveness and safety of tofacitinib and vedolizumab as a second-line therapy in anti-TNFs experienced patients ulcerative colitis: preliminary results of an IGIBD study (VE2TO-UC)

10. The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease

18. PC.01.9 HYPOMETHYLATION OF LINE-1 IN SMALL BOWEL CARCINOMAS AND COELIAC DISEASE

21. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies.

25. LINEE GUIDA EUROEE

26. Are ureteral stent-related symptoms detectable in transplanted patients? milder, but they are. Results from a prospective observational cohort study

27. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy

28. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines

31. P301 Non-familial small bowel carcinomas in Crohnʼs disease: clinico-pathological, molecular and prognostic features

32. OP005 The PROSIT cohort of infliximab biosimilar in IBD: a prolonged follow-up on the efficacy and safety across Italy

36. T.04.3 FREQUENCY AND RISK FACTORS FOR FRAILTY IN IBD PATIENTS

37. T.06.8 COMPARATIVE OBJECTIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN A REAL-LIFE COHORT OF ACTIVE CROHN’S DISEASE PATIENTS FAILURE TO TNF INHIBITORS

39. T.06.7 INCIDENT COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE

40. COVID-19 and kidney transplantation: an Italian Survey and Consensus

41. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

42. Digestive diseases. 2022-2025 edition

43. Surgery Due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an Ecco Confer Multicentre Case Series (Scar Study)

44. Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey

45. Robotic radical prostatectomy for prostate cancer in renal transplant recipients: Results from a multicenter series

46. P487 Surgery due to inflammatory bowel disease during pregnancy: mothers and offspring outcomes (SCAR Study)

47. P613 Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn’s disease patients failure to TNF inhibitors

48. Poorly cohesive carcinoma of the nonampullary small Intestine: A distinct histologic subtype with prognostic significance

49. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.

Catalog

Books, media, physical & digital resources